Periodic Reporting for period 4 - OligoGpivotalCF (A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis)

The objective of the project is to advance the orphan drug OligoG through a pivotal phase IIb clinical trial, to enable a new and improved therapeutic approach for the orphan disease cystic fibrosis (CF). The study drug is an alginate oligosaccharide derived from seaweed...